Exploring how Clusterin affects brain cell development in Alzheimer's disease
Understanding the impact of Clusterin on the oligodendrocyte lineage in AD
This study is looking at how a protein called Clusterin affects the brain cells that help repair myelin, which is important for brain health, in people with Alzheimer's disease, to find new ways to help improve memory and thinking skills.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10539074 on NIH RePORTER |
What this research studies
This research investigates the role of Clusterin, a protein linked to Alzheimer's disease, in the development of oligodendrocyte progenitor cells (OPCs) that are crucial for myelin repair in the brain. The study aims to understand why these cells fail to produce myelin in Alzheimer's patients, which is believed to contribute to cognitive decline. By examining the relationship between Clusterin levels and myelin disruption, the research seeks to uncover new insights that could lead to effective therapies for Alzheimer's disease. The approach includes using mouse models and analyzing genetic factors associated with the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with Alzheimer's disease or exhibit early signs of cognitive decline.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance myelin repair and improve cognitive function in Alzheimer's patients.
How similar studies have performed: While the specific role of Clusterin in OPCs and myelination in Alzheimer's has not been previously studied, related research has shown promising results in understanding myelin disruption in neurodegenerative diseases.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Gaultier, Alban P — University of Virginia
- Study coordinator: Gaultier, Alban P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.